On day −4, their splenocytes were harvested and incubated with PLP139 and IL-2 for 72 h, a protocol that has been shown to expand Tregs in vitro and used in clinical protocols for Treg immunotherapy of organ transplant and type 1 diabetes (25–28). This evidence concerns the gene IL2 and type 1 diabetes mellitus.